T1	Participants 721 807	hypertensive patients of the European Lacidipine Study on Atherosclerosis (ELSA) trial
T2	Participants 1314 1501	Patients in whom at least seven clinic (6-month intervals) or at least three (yearly intervals) 24-h values were available from the end of the drug titration phase to the end of the study